Immunotherapy Chemotherapy Epigenetics Tyrosine Kinase Inhibitors Proteasome Inhibitors Serine-Threonine Kinase Inhibitors BCL Inhibitors Other CD Protein Inhibitors Immune Checkpoint Inhibitors Cyclin Dependent Kinase Inhibitors | Diffuse Large B Cell Lymphoma | Mantle Cell Lymphoma | Multiple Myeloma | Thyroid Gland Carcinoma | Gastric Cancer | Pancreatic Ductal Adenocarcinoma | Acute Myelogenous Leukemia | Non Small Cell Lung Cancer | Lymphoma | Triple Negative Breast Cancer | Hepatocellular Cancer | Small Cell Lung Cancer | Mediastinal B Cell Lymphoma | Cervical Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
azacitidine oral | ||||||||||||||
lisocabtagene maraleucel | ||||||||||||||
GS-626510 | ||||||||||||||
TG-1701 | ||||||||||||||
bortezomib | ||||||||||||||
MLN8237 | ||||||||||||||
INCB57643 | ||||||||||||||
venetoclax | ||||||||||||||
WB100 | ||||||||||||||
MRT-2359 | ||||||||||||||
ICX-101 | ||||||||||||||
HX301 | ||||||||||||||
tisagenlecleucel-T | ||||||||||||||
brusatol | ||||||||||||||
ROS1 inhibitor | ||||||||||||||
PD-L1 inhibitor + MYC inhibitor |